DelCureLifeSciences Ltd.: An endeavor to change lives by managing healthcare

The evolution of the Indian pharmaceutical industry has been vast. Till the 1970s, the Indian market was dominated by foreign companies with drugs being imported and accumulated in the country. But now, it has been growing at record levels and made its way to the top largest exporters of pharmaceutical products across the globe. The pharmaceutical industry is now one of the most premier business segments of India, accounting for about 5% of total exports. As the industry grows at a compounded annual growth rate, pharmaceutical companies are also focusing on improving operational efficiency and productivity, compliance with manufacturing and quality standards and also R&D and innovation to establish their position among the world leaders.

In the light of the above mentioned, we are pleased to present you DelCureLifeSciences Ltd, an innovative pharmaceutical company with an aim to bring differentiated high quality products through international collaboration with companies from the USA, Switzerland, and Turkey.

DelCureLifeSciences was incorporated on 31st January, 2013 with the goal of making good quality, affordable medicines that can be made accessible across the globe and provide healthier life options to the society. The company envisions of becoming the most respected and uniquely positioned leading pharmaceutical company in the chosen areas or specialty verticals in India and abroad with distinct value based characteristics. While commencing its marketing operations in 2013, it launched its first division, Winspire with 300 members in Paediatrics, ENT and Chest specialties. This division’s break through products provided greater and faster relief to patients, resulting in its wide popularity. Soon, it launched its second division called DelVoice in 2013. DelVoice is a multispecialty division with a focus towards Orthopaedics, Gastroenterologists and Consulting Physicians.

Today this young company has become a full scale pharmaceutical company proving its significance through world class products and going beyond profit to invest in humanitarian led initiatives like “Honour Your Doctor-Respect Doctor, Save Society”.

DelCure: A class apart

“If you manufacture and provide products that you, as producer can recommend to your own family members without hesitation then your product has unbeaten quality and we make such products”, says DelCure. The company maintains product differentiation and adopts upstream market strategy based on in-depth understanding of customers and continued market research.

DelCure has “NO COMPROMISE” policy with regard to the quality of its products. DelCureLifeSciences uses patented technology to deliver top class differentiated and innovative products in the field of Pediatrics, ENT and Chest specialties through its Winspire Team and in the field of Orthopedics, Gastroenterologists and General medicines through its team Delvoice. It works closely with all its associated doctors to develop breakthrough products- all highly effective, fast and affordable.

Position in the current domain

Pharmaceutical industry is still struggling in several areas including political pressure, conventional business practices and resistance towards change. DelCureLifeSciences is trying immensely to overcome the constraints. Though few of them like political ignorance cannot be changed, the company works relentlessly in areas it can improve like breaking conventional, accepting digitization, promoting technology and transparent way of working. PHYGITAL, a digital platform to stay connected with doctors rather than knocking on their door, is one such measure adopted by the company.

Very early in the business, DelCure realised that data is invaluable and will define the course of relationship in future. Aiming to establish long lasting relationships, DelCure developed a very exhaustive database of its clients (Doctors) that goes beyond the general information of birthdays & anniversaries, which is still not available with any other competitor. They have included the merits, credits and educational achievements of each doctor to have a complete profile in order to carefully associate with relevant doctors for their CME educational programs like Paediatric Insight that can help aspiring doctors to learn from the experienced.

The promise of a better healthcare

DelCure has its goal set and its eyes focused on the path to be a technological leader with innovative products and harmonious relationships with all its clients. The company aims to report 3 times more growth than the represented market growth rate. It has collaborated with an esteemed European company and is all set to launch, by August 2018, the first licensed European products to address the needs of pediatric neurology, having a business potential of over INR 15 crores in 1st year. The company is also working towards establishing direct relationship with end user for its nutraceutical portfolio in pediatrics and orthopedics.

DelCure dreams of becoming one of the top 10 companies of the Indian Pharmaceutical industry in the coming years. Mr. Prashant Pathak wishes to design a technology driven marketing company that can reach new customers, providing end to end differentiated experience to customers based on deep understanding of huge databases of information. DLL is planning to digitize the existing systems, and use Artificial Intelligence to bring down the cost and provide customized solutions based on the huge pool of information to patients and prescribers thereby making a mark on the global map.

Meet the thought leader 

Prashant Kumar Pathak, CEO

Prashant Pathak is the CEO and Managing Director of DelCureLifeSciences Limited (DLL).With a dream of making modern medicines affordable and within reach of the poor, Prashant started his pharmaceutical entrepreneurship journey. He is a science graduate by qualification and with training in SFE & SFA by IBC, Singapore and Sales & Marketing Management at ASCI, Hyderabad. Having vast experience of over 3 decades in the pharmaceutical industry in Sales & Marketing, International Business, Supply Chain Management and Operations, Prashant has also served as Chief Executive – Global Formulations with RPG Lifesciences and Senior Director – Sales & Marketing with Dr. Reddy’s Laboratories.

“At DelCureLifeSciences, we strongly believe in promoting the purpose of Happiness and creating the culture of Helpfulness for DLL family members and the society, with the learning from Mother Nature, promoting sustainability and augmenting life with growth. We firmly believe in value of Truthfulness.”